Figure 2From: A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder Adjusted mean scores on HAM-D 17 (ANCOVA), LOCF data, ITT population. Back to article page